Standard
PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy. / Steiniche, T; Vestergaard Danielsen, A; Wang, Z; Feng, Y; Switten Nielsen, P; Bastholt, L; Schmidt, H; Svane, I M; Dolled-Filhart, M; Emancipator, K; Weiner, R; Busch-Sørensen, M; Zhou, W.
I:
Journal of the European Academy of Dermatology and Venereology, Bind 31, Nr. 7, 2017, s. e319-e321.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning
Harvard
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H
, Svane, IM, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, '
PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy',
Journal of the European Academy of Dermatology and Venereology, bind 31, nr. 7, s. e319-e321.
https://doi.org/10.1111/jdv.14106APA
Steiniche, T., Vestergaard Danielsen, A., Wang, Z., Feng, Y., Switten Nielsen, P., Bastholt, L., Schmidt, H.
, Svane, I. M., Dolled-Filhart, M., Emancipator, K., Weiner, R., Busch-Sørensen, M., & Zhou, W. (2017).
PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy.
Journal of the European Academy of Dermatology and Venereology,
31(7), e319-e321.
https://doi.org/10.1111/jdv.14106Vancouver
Steiniche T, Vestergaard Danielsen A, Wang Z, Feng Y, Switten Nielsen P, Bastholt L o.a.
PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy.
Journal of the European Academy of Dermatology and Venereology. 2017;31(7):e319-e321.
https://doi.org/10.1111/jdv.14106Author
Steiniche, T ; Vestergaard Danielsen, A ; Wang, Z ; Feng, Y ; Switten Nielsen, P ; Bastholt, L ; Schmidt, H ; Svane, I M ; Dolled-Filhart, M ; Emancipator, K ; Weiner, R ; Busch-Sørensen, M ; Zhou, W. / PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy. I: Journal of the European Academy of Dermatology and Venereology. 2017 ; Bind 31, Nr. 7. s. e319-e321.
Bibtex
@article{2350dac86b1f4c82b07973c62279198e,
title = "PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy",
author = "T Steiniche and {Vestergaard Danielsen}, A and Z Wang and Y Feng and {Switten Nielsen}, P and L Bastholt and H Schmidt and Svane, {I M} and M Dolled-Filhart and K Emancipator and R Weiner and M Busch-S{\o}rensen and W Zhou",
year = "2017",
doi = "10.1111/jdv.14106",
language = "English",
volume = "31",
pages = "e319--e321",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Elsevier",
number = "7",
}
RIS
TY - JOUR
T1 - PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy
AU - Steiniche, T
AU - Vestergaard Danielsen, A
AU - Wang, Z
AU - Feng, Y
AU - Switten Nielsen, P
AU - Bastholt, L
AU - Schmidt, H
AU - Svane, I M
AU - Dolled-Filhart, M
AU - Emancipator, K
AU - Weiner, R
AU - Busch-Sørensen, M
AU - Zhou, W
PY - 2017
Y1 - 2017
U2 - 10.1111/jdv.14106
DO - 10.1111/jdv.14106
M3 - Comment/debate
C2 - 28045203
VL - 31
SP - e319-e321
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
SN - 0926-9959
IS - 7
ER -
